205-472-3 | Sigma-Aldrich

Quality Control Range Sheet- B6062-102 and B6062-202

pg/mL CTACK Control 1 132 – 275 pg/mL INFω Control 1 84 – 174 pg/mL Control 2 472 – 980 pg/mL Control 2

XP725 Antibody Number-Lot Number 071M4826

420 441 442 443 444 465 466 467 468 5.4 397 398 399 400 421 422 423 424 445 446 447 448 469 470 471 472 5.5 401 402 403 404 425 426 427 428 449 450 451 452 473 474 475

GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor

Genet., 29, 465-468(2001). 74. Stoker, A. and Dutta, R. BioEssays, 20, 463-472 (1998). 75. Ratcliffe, C.F., et al., Nat. Neurosci., 3, 437-444 (2000). 76. Fujikawa, A., et al., Nat. Genet., 33, 375-381 (2003

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

31 499 15 4009 30 515 13 3860 31 472 13 3887 33 767 20 1357 22 4445 30 1919 31 IPI00022429 a-1-acid glycoprotein 1 precursor 103 4 118 4 94 4 220 5 86 3 168 6 107

XP725 Antibody List Lot 089K4791

005159.1 y y n/d 44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d 47 ATM A6093 472 ATM M NP_000042.3 y n/d n/d 49 ATM A6218 472 ATM M NP_000042.3 y n/d n/d 55 BAK B5897 578 BAK1 P NP_001179.1 y n/d

XP725 Antibody List Lot 129K4830

005159.1 y y n/d 44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d 47 ATM A6093 472 ATM M NP_000042.3 y n/d n/d 49 ATM A6218 472 ATM M NP_000042.3 y n/d n/d 55 BAK B5897 578 BAK1 P NP_001179.1 y n/d

XP725 Antibody List Lot 129K4831

005159.1 y y n/d 44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d 47 ATM A6093 472 ATM M NP_000042.3 y n/d n/d 49 ATM A6218 472 ATM M NP_000042.3 y n/d n/d 55 BAK B5897 578 BAK1 P NP_001179.1 y n/d

Protein Tyrosine Phosphatases- Potential Roles in Disease

Genet., 29, 465-468(2001). 74. Stoker, A. and Dutta, R. BioEssays, 20, 463-472 (1998). 75. Ratcliffe, C.F., et al., Nat. Neurosci., 3, 437-444 (2000). 76. Fujikawa, A., et al., Nat. Genet., 33, 375-381 (2003

XP725 Antibody List

1386 Atf2,ATF2 NP_112280.1,NP_033845.1,NP_001871.2 M y y y 47 ATM A6093 472 ATM NP_612149.1 M y n/d n/d 48 Anti Cy3+Cy5 49 ATM A6218 472 ATM NP_612149.1 M y n/d n/d 50 Aurora-B A5102 9212, 20877, 114592 Aurkb

XP725 Antibody List 013M4793

Atf2,ATF2 NP_112280.1,NP_033845.1,NP_001871.2 M y y y 47 ATM A6093 472 ATM NP_612149.1 M y n/d n/d 48 Anti Cy3+Cy5 C0992 49 ATM A6218 472 ATM NP_612149.1 M y n/d n/d 50 Aurora-B A5102 9212, 20877, 114592

White Paper - The Message in the Marks: Deciphering Cancer Epigenetics

Bladder urothelial carcinoma 507 Head and neck squamous-cell carcinoma 463 Lung adenocarcinoma 472 *Adapted from Jacobsen, A et al. 2013 Precursor miRNA Mature miRNA A. Destabilization B

Cytoskeletal Signaling Antibodies, Reagents and Kits

Antibody Anti-PTP-1B H M WB Pur Rb IgG 50 µg 07-088 Anti-PTPα H M R WB APur Rb IgG 100 µL 07-472 Protein PTP-1B PA 10 µg 14-621 PTP-1B, active, agarose conj. PA 50 µg

List of Antibodies

//www.sigmaaldrich.com/ProductLookup.html?ProdNo=T2949&Brand=SIGMA� y y 549 PAD14 P 472 Munc-18-1 M2694 P n/d y y 473 Munc-13/1 M6194 M n/d y y 474 MyD88 M9934 P y y n/d 475 Myosin M1570

Halal Certificate

A20251 HC-24SIA708 471. cis-3-Hexenyl 2-Methylbutanoate W349700 C41922 HC-24SI7M39 472. CIS-3-HEXENYL 3-METHYLBUTANOATE 97%, FCC, FG W349801 B38841 HC-24SI7236 473. CIS-3-HEXENYL ACETATE 98%, FCC

Halal Certificate

A20251 HC-22SIIA06 471. cis-3-Hexenyl 2-Methylbutanoate W349700 C41922 HC-22SI2I37 472. CIS-3-HEXENYL 3-METHYLBUTANOATE 97%, FCC, FG W349801 B38841 HC-22SIES34 473. CIS-3-HEXENYL ACETATE 98%, FCC

XP725 Worksheet for Lot Number 071M4826

D3938 469 3 2 5 5 DR6 D1564 470 3 2 5 6 DR6 D1564 471 3 2 5 7 DRAK1 D1314 472 3 2 5 8 DRAK1 D1314 473 3 2 6 1 Dystrophin D8168 474 3 2 6 2 Dystrophin D8168 475 3 2 6

3D BIOPRINTING: Printing a Brighter Future

K.; Lanzi, A. M.; Haygan, N.; Yoo, S. S.; Vincent, P. A.; Dai, G. Cell. Mol. Bioeng. 2014, 7 (3), 460–472. (18) Song, K. H.; Highley, C. B.; Rouff, A.; Burdick, J. A. Adv. Funct. Mater. 2018, 28 (31

3D BIOPRINTING: Printing a Brighter Future

K.; Lanzi, A. M.; Haygan, N.; Yoo, S. S.; Vincent, P. A.; Dai, G. Cell. Mol. Bioeng. 2014, 7 (3), 460–472. (18) Song, K. H.; Highley, C. B.; Rouff, A.; Burdick, J. A. Adv. Funct. Mater. 2018, 28 (31

Chrombook 2015 - The world of chromatography in your hands

0 1 2 3 4 5 6 Intensity [x=107] 0 2 4 6 8 10 12 Time [min] EIC 209; 253; 507 – All MS EIC 197; 241; 483 – All MS EIC 161;

Acta Interactive Archive Vol 51

Lett. 2016, 18, 5170. (16) Peng, Y.; Xu, X.-B.; Xiao, J.; Wang, Y.-W. Chem. Commun. 2014, 50, 472. (17) Yan, C.-S.; Peng, Y.; Xu, X.-B.; Wang, Y.-W. Chem.—Eur. J. 2012, 18, 6039. (18) Phapale